Cohorts included patients who were on standard budesonide and formoterol therapy and patients who were on this standard therapy as well as a GLP-1 receptor agonist, which included semaglutide, tirzepatide, exenatide, dulaglutide or liraglutide, with 1,066 patients in each group
Ready to explore longevity treatments
What is Lavender Sky Health
When used as monotherapy or with metformin, the risk of hypoglycaemia is generally low due to the glucose-dependent mechanism of action
206 Combined administration of shikonin and cisplatin increases Fe 2+ , ROS, and lipid peroxidation (LPO) levels and downregulates GPX4 in ovarian cancer cells, reducing cisplatin resistance by inducing ferroptosis